Invagen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INVAGEN PHARMS, and what generic and branded alternatives to INVAGEN PHARMS drugs are available?
INVAGEN PHARMS has sixty-one approved drugs.
There is one tentative approval on INVAGEN PHARMS drugs.
Summary for Invagen Pharms
| US Patents: | 0 |
| Tradenames: | 52 |
| Ingredients: | 52 |
| NDAs: | 61 |
Drugs and US Patents for Invagen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Invagen Pharms | TERBINAFINE HYDROCHLORIDE | terbinafine hydrochloride | TABLET;ORAL | 077533-001 | Jul 2, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Invagen Pharms | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | TABLET;ORAL | 202942-001 | Feb 5, 2014 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Invagen Pharms | TOPIRAMATE | topiramate | TABLET;ORAL | 079162-004 | Mar 27, 2009 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Invagen Pharms | TRANDOLAPRIL | trandolapril | TABLET;ORAL | 078320-002 | Jun 12, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Invagen Pharms | SEVELAMER CARBONATE | sevelamer carbonate | TABLET;ORAL | 203860-001 | Oct 26, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Invagen Pharms | LANREOTIDE ACETATE | lanreotide acetate | SOLUTION;SUBCUTANEOUS | 215395-001 | Dec 17, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Invagen Pharms | ZOLMITRIPTAN | zolmitriptan | TABLET;ORAL | 204284-001 | Apr 9, 2014 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Invagen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Invagen Pharms | LEUPROLIDE ACETATE FOR DEPOT SUSPENSION | leuprolide acetate | FOR SUSPENSION;INTRAMUSCULAR | 205054-001 | Aug 28, 2018 | 9,789,064 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
